Throat News and Research

RSS

Sleep disorders increase health care utilization and costs

Sleep disorders are associated with significantly higher rates of health care utilization, conservatively placing an additional $94.9 billion in costs each year to the United States health care system, according to a new study from researchers at Mass Eye and Ear, a member hospital of Mass General Brigham.

7 May 2021

Increased symptomatic levels of COVID-19 may be associated with psychiatric symptoms

A significant level of symptoms of depression, anxiety and post-traumatic stress may follow COVID-19 independent of any previous psychiatric diagnoses, according to new research by Columbia University Mailman School of Public Health with colleagues at Universidade Municipal de São Caetano do Sul in Brazil.

7 May 2021

Telemedicine is a tool — not a replacement for your doctor’s touch

Earlier in the pandemic it was vital to see doctors over platforms like Zoom or FaceTime when in-person appointments posed risks of coronavirus exposure. Insurers were forced — often for the first time — to reimburse for all sorts of virtual medical visits and generally at the same price as in-person consultations.

6 May 2021

Glandular fever associated with greater risk of depression

New research shows that patients who have had contact with the hospital due to serious glandular disease have a greater risk of subsequently developing depression.

3 May 2021

Delayed antibiotic prescribing unlikely to lead to poorer symptom control

Delayed antibiotic prescribing is a safe and effective strategy for most patients with respiratory tract infections, finds an analysis of patient data published by The BMJ today.

30 Apr 2021

U-M study finds low HPV vaccination rate among young adult men in the U.S.

The COVID-19 vaccine isn't having any trouble attracting suitors. But there's another, older model that's been mostly ignored by the young men of America: the HPV vaccine.

27 Apr 2021

Doctoral students recommend changing the protocols around use of tear gas on crowds

A new study by five doctoral students in neuroscience at the University of Minnesota Medical School calls attention to a lack of regulation and unknown long-term health effects of tear gas. Based on their research, the group recommends changing the protocols around the use of tear gas as a crowd control measure at both the local and national level.

27 Apr 2021

Doctors scramble to understand long Covid, but causes and prognosis are elusive

One night in March 2020, Joy Wu felt like her heart was going to explode. She tried to get up and fell down. She didn't recognize friends' names in her list of phone contacts. Remembering how to dial 9-1-1 took "quite a bit of time," she recalled recently.

22 Apr 2021

All-in-one test provides a promising solution for COVID-19 detection and mutational surveillance

A new type of COVID-19 testing strategy could help streamline the process of identifying cases, tracking variants and detecting co-infecting viruses.

20 Apr 2021

Humana health plan overcharged Medicare by nearly $200 million, federal audit finds

A Humana Inc. health plan for seniors in Florida improperly collected nearly $200 million in 2015 by overstating how sick some patients were, according to a new federal audit, which seeks to claw back the money.

20 Apr 2021

Bristol-based new biotech company is developing ground-breaking treatments for Covid-19

A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented potential treatments for Coronavirus.

16 Apr 2021

More than half of COVID-19 patients report persistent symptoms 12-months after infection

In a new study, appearing on the pre-print server medRxiv*, researchers at the University of Trieste and Istituto Auxologico Italiano IRCCS in Italy report that more than half of patients with previous mild-to-moderate symptomatic COVID-19 complained of the persistence of at least one symptom 12-months after the onset of the illness.

15 Apr 2021

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared with those infected with a different COVID-19 strain.

13 Apr 2021